Orbis Health Solutions LLC Patent applications |
Patent application number | Title | Published |
20150224126 | COMPOSITIONS AND METHODS FOR TISSUE REGENERATION - Methods and compositions using an orthosilicate for tissue regeneration, such as to treat a disease or condition, are described, including on the skin. Also described are methods for making such compositions. | 08-13-2015 |
20140329751 | METHOD FOR SENSITIZING CELLS TO CANCER THERAPY - Disclosed herein are compositions and methods useful for the treatment of cancer, such as breast cancer. In some embodiments, the methods and compositions include human prolactin, or human prolactin in conjunction with a cytotoxic agent. In other embodiments, the methods and compositions include one or more of human prolactin, growth hormone and placental lactogen, or one or more of human prolactin, growth hormone and placental lactogen in conjunction with a cytotoxic agent. In some embodiments, the cytotoxic agent comprises a chemotherapeutic agent. | 11-06-2014 |
20140248316 | HYBRID CELLS FOR TREATING CANCER PATIENTS - The present invention relates to cancer treatment compositions and methods for treating a specific cancer patient population. In particular, the application describes methods of treating a patient with cancer, such as a neuroblastoma, with a hybrid cell preparation. | 09-04-2014 |
20140161912 | COMPOSITIONS AND METHODS FOR TISSUE REGENERATION - Methods and compositions using an orthosilicate for tissue regeneration, such as to treat a disease or condition, are described, including on the skin. Also described are methods for making such compositions. | 06-12-2014 |
20140065190 | TUMOR LYSATE LOADED PARTICLES - Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the Major Histocompatibility Complex class I pathway and can be used as a vaccine to treat cancer, including ocular melanoma. | 03-06-2014 |
20140065173 | TUMOR LYSATE LOADED PARTICLES - Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the Major Histocompatibility Complex class I pathway and can be used as a vaccine to treat cancer, including ocular melanoma. | 03-06-2014 |
20130131640 | METHOD OF CREATING AND SORTING FUSED CELLS - An efficient and simplified method for preparing and sorting fused cells is described herein. This approach yields fused cells useful in a variety of applications, including clinical treatment regimens, as cellular modulators of the immune system. | 05-23-2013 |
20130040876 | METHOD FOR SENSITIZING CELLS TO CANCER THERAPY - Disclosed herein are compositions and methods useful for the treatment of cancer, such as breast cancer. In some embodiments, the methods and compositions include human prolactin, or human prolactin in conjunction with a cytotoxic agent. In other embodiments, the methods and compositions include one or more of human prolactin, growth hormone and placental lactogen, or one or more of human prolactin, growth hormone and placental lactogen in conjunction with a cytotoxic agent. In some embodiments, the cytotoxic agent comprises a chemotherapeutic agent. | 02-14-2013 |